A Transdisciplinary Panel on CRISPR/Cas9 2018-02-13 10:30:00

Back to Events

Start:Tuesday, 13 February 2018Time:10:30
End:Tuesday, 13 February 2018Time:12:30
Category: Non-SCS events

Science Policy Session consequat. as part of sunt the LS2 Annual occaecat Meeting 2018:
- exercitation Martin Jinek, University of deserunt Zurich
- Bruno ex Lemaitre, EPF Lausanne
- ut Effy Vayena, Chair of exercitation Bioethics, Health Ethics officia & Policy Lab, Dep. cupidatat of Health Sciences cillum & Technology, ETHZ)
- Heinz Müller, Swiss ipsum Federal Institute of cillum Intellectual Property, Bern
Moderation: Nik Walter exercitation (Tages-Anzeiger/SonntagsZeitung)

Venue: University of Lausanne, Amphimax/Amphipôle
Detailed DescriptionThe CRISPR/Cas9 revolution is widely being talked about these days. Apart from being a major scientific breakthrough, it also reveals how different fears and hopes are being handled by science, society, economy, and policy makers. The CRISPR/Cas9 system thus represents an ideal case to discuss the different implications of modern biomedical research, from economical, legal and ethical implications, to aspects of scientific impact and careers. The transdisciplinary panel will give the stage to experts from different fields to then discuss all these aspects around one technology.

Attendance to the panel only is free.
Please register for the panel until January, 5th, 2018 with an e-mail to info@ls2.ch
Email: Send
Website: http://www.annual-meeting.ls2.ch
Event Type
This event is public. Anyone can attend and invite others to attend.
Spichiger David (creator)